studi
report
heterolog
express
pichia
pastori
activ
neuraminidas
deriv
avian
influenza
viru
aviet
gene
encod
neuraminidas
head
domain
residu
fuse
directli
infram
saccharomyc
cerevisia
secret
signal
ppicz
vector
recombin
neuraminidas
express
p
pastori
kda
secret
solubl
protein
glycopeptidas
f
treatment
gener
kda
product
indic
secret
recombin
neuraminidas
nlink
glycoprotein
kinet
studi
inhibit
test
oseltamivir
carboxyl
demonstr
recombin
neuraminidas
similar
k
k
valu
viral
neuraminidas
yeastbas
heterolog
express
system
provid
function
activ
recombin
neuraminidas
use
antiinfluenza
drug
screen
also
potenti
proteinbas
vaccin
pathogen
avian
influenza
viru
highli
contagi
among
bird
includ
poultri
sever
contin
pose
seriou
threat
human
health
evidenc
increas
number
virusinfect
patient
abdelghafar
et
al
capua
alexand
de
jong
hien
joseph
subbarao
ligon
yuen
wong
date
peopl
worldwid
infect
viru
cumul
casefat
rate
approach
owe
virul
high
lethal
endem
presenc
increasingli
larg
host
reservoir
signific
ongo
mutat
viru
potenti
becom
signific
pandem
threat
effect
control
epidem
includ
effect
vaccin
antiviraldrug
treatment
howev
influenza
vaccin
effici
antigen
variat
therefor
earli
infect
period
prevent
treatment
patient
infect
must
reli
mainli
antivir
drug
treatment
oral
oseltamivir
tamiflu
inhal
zanamivir
relenza
bardsleyelliot
nobl
colman
doucett
aoki
leneva
et
al
mckimmbreschkin
moscona
woodhead
et
al
drug
target
type
ii
integr
membran
glycoprotein
neuraminidas
na
found
virion
surfac
na
remov
termin
sialic
acid
residu
glycoconjug
allow
releas
viral
progeni
infect
cell
prevent
viral
aggreg
burnet
gottschalk
griffin
et
al
liu
et
al
inhibit
na
activ
limit
spread
viral
infect
therebi
suppress
onset
diseas
colman
oseltamivir
recommend
earli
treatment
confirm
strongli
suspect
infect
stockpil
mani
countri
treatment
pandem
influenza
schunemann
et
al
prophylact
therapeut
efficaci
oseltamivir
well
establish
uncompl
season
humaninfluenza
infect
clinic
effect
oseltamivir
human
infect
remain
somewhat
limit
crusat
de
jong
addit
accumul
studi
shown
particular
strain
virus
develop
resist
oseltamivir
surveil
na
inhibitorresist
ongo
aoki
et
al
escuret
et
al
ferrari
lina
handel
et
al
hayden
et
al
le
et
al
mckimmbreschkin
mendel
sidwel
moscona
reec
yen
et
al
recent
oseltamivirresist
isol
carri
critic
mutat
na
identifi
patient
die
infect
despit
earli
initi
oseltamivir
therapi
de
jong
et
al
le
et
al
rais
major
concern
oseltamivirresist
variant
may
becom
widespread
henc
utmost
import
prepar
emerg
oseltamivirresist
virus
advent
pandem
develop
novel
na
inhibitor
screen
novel
inhibitor
na
requir
adequ
amount
pure
na
also
activ
catalyt
na
prepar
convent
proteolyt
cleavag
detergenttreat
viral
envelop
follow
subsequ
purif
obtain
catalyt
na
head
domain
de
barro
et
al
gallagh
et
al
hocart
et
al
kilbourn
et
al
russel
et
al
seto
rott
takimoto
et
al
ward
et
al
use
method
head
domain
na
extract
viral
particl
suffici
amount
studi
threedimension
structur
russel
et
al
howev
largescal
product
viral
particl
requir
inocul
embryon
chicken
egg
procedur
restrict
limit
number
laboratori
confound
inadequ
yield
puriti
viru
adapt
heterolog
express
system
provid
altern
mean
viral
protein
product
compar
heterolog
recombin
protein
express
use
mammalian
insect
cell
line
methylotrop
yeast
p
pastori
consid
simplest
organ
capabl
posttransl
modif
product
protein
larg
amount
either
intracellularli
extracellularli
bretthauer
castellino
cereghino
et
al
cereghino
cregg
cregg
et
al
addit
p
pastori
potenti
adapt
safe
inexpens
largescal
ferment
p
pastori
express
system
use
produc
number
viral
protein
includ
hepat
viru
protein
chen
han
et
al
envelop
glycoprotein
scorer
et
al
viral
capsid
antigen
epsteinbarr
viru
hu
et
al
influenza
viru
rna
polymeras
hwang
et
al
sar
coronaviru
nucleocapsid
protein
liu
et
al
dengu
viru
envelop
protein
et
al
rubella
viru
glycoprotein
wen
wang
hemagglutinin
avian
influenza
viru
subtyp
wang
et
al
xu
et
al
studi
first
success
heterolog
express
report
avian
influenza
viru
aviet
na
head
domain
use
p
pastori
construct
express
vector
applic
produc
recombin
na
secret
nlink
glycoprotein
describ
addit
shown
recombin
na
function
activ
similar
kinet
properti
viral
na
gene
genbank
access
no
respect
deriv
avian
influenza
virus
aviet
respect
obtain
recombin
plasmid
kindli
provid
dr
erich
hoffmann
st
jude
children
research
hospit
gene
modifi
remov
polybas
amino
acid
code
region
known
associ
high
virul
webbi
et
al
reversegenet
virus
gener
plasmid
revers
genet
system
hoffmann
et
al
reversegenet
viral
gene
except
deriv
oseltamivir
carboxyl
acid
kind
gift
dr
tirayut
vilaivan
depart
chemistri
faculti
scienc
chulalongkorn
univers
thailand
gene
encod
na
head
domain
residu
avian
influenza
viru
aviet
pcr
amplifi
use
forward
primer
na
f
gcctcgagaaaagagtaaaattagcggg
revers
primer
na
r
gctctagacccttgtcaatggtgaatgg
contain
xhoi
xbai
restrict
site
underlin
respect
pcr
conduct
total
volum
l
contain
mm
mgcl
dntp
u
dynazym
ext
dna
polymeras
finnzym
finland
ng
nm
primer
thermal
cycl
geneamp
pcr
system
appli
biosystem
foster
citi
ca
usa
perform
follow
c
min
follow
cycl
c
c
c
min
final
step
c
min
pcr
amplicon
separ
agaros
gelelectrophoresi
purifi
use
qiaquick
gel
extract
kit
qiagen
valencia
ca
usa
amplicon
digest
xhoi
xbai
promega
madison
wi
usa
subclon
express
vector
invitrogen
carlsbad
ca
usa
recombin
plasmid
transform
escherichia
coli
use
standard
heat
shock
method
sambrook
et
al
transform
harbor
select
low
salt
lb
agar
contain
gml
zeocin
tm
follow
plasmid
extract
use
qiaprep
miniprep
kit
qiagen
valencia
ca
usa
na
gene
presenc
verifi
restrict
enzym
digest
dna
sequenc
bioservic
unit
nation
center
genet
engin
biotechnolog
bangkok
thailand
recombin
plasmid
valid
na
gene
sequenc
linear
pmei
digest
transform
p
pastori
invitrogen
carlsbad
ca
usa
electropor
biorad
gene
pulser
biorad
hercul
ca
usa
set
kv
f
transform
grown
yeast
extract
pepton
dextros
yepd
agar
plate
contain
gml
zeocin
tm
coloni
select
screen
naintegr
coloni
pcr
screen
use
forward
revers
aox
primer
invitrogen
carlsbad
ca
usa
pcr
conduct
total
volum
l
contain
mm
mgcl
dntp
u
dynazym
ii
dna
polymeras
finnzym
finland
l
cell
suspens
nm
primer
thermal
cycl
perform
follow
c
min
follow
cycl
c
c
c
min
final
step
c
min
amplicon
analyz
agaros
gelelectrophoresi
describ
singl
integrantcontain
coloni
inocul
yepd
media
contain
gml
zeocin
tm
incub
c
h
shake
rpm
cell
cultur
transfer
fresh
bmgi
medium
mm
phosphat
buffer
ph
wv
yeast
nitrogen
base
wv
yeast
extract
wv
pepton
wv
biotin
vv
glycerol
grown
od
reach
cell
harvest
resuspend
bmmi
medium
mm
potassium
phosphat
ph
wv
yeast
nitrogen
base
wv
yeast
extract
wv
pepton
wv
biotin
absolut
methanol
ad
h
growth
final
concentr
vv
respect
time
point
cell
cultur
supernat
collect
determin
na
express
enzym
activ
protein
express
p
pastori
conduct
neg
control
monitor
express
secret
na
protein
cell
cultur
supernat
separ
sdspage
laemmli
protein
band
visual
stain
coomassi
brilliant
blue
ultra
pure
usb
corpor
cleveland
oh
usa
identifi
glycoprotein
p
pastori
cultur
supernat
digest
nglycosidas
f
pngase
f
new
england
biolab
usa
accord
manufactur
protocol
separ
sdspage
gel
stain
use
silversnap
stain
kit
ii
gelcod
glycoprotein
stain
kit
pierc
rockford
il
usa
immunoblot
conduct
use
mous
antihisprob
monoclon
igg
antibodi
santa
cruz
biotechnolog
ca
usa
primari
antibodi
goat
antimous
igg
conjug
horseradish
peroxidas
hrp
santa
cruz
biotechnolog
ca
usa
secondari
antibodi
addit
mous
antiserum
recombin
na
kindli
provid
dr
potjane
srimanot
graduat
program
biomed
scienc
faculti
alli
health
scienc
thammasat
univers
rangsit
center
thailand
rabbit
polyclon
antina
antibodi
unit
state
biolog
usa
also
use
primari
antibodi
subsequ
probe
goat
antimous
igghrp
goat
antirabbit
igghrp
santa
cruz
biotechnolog
ca
usa
respect
protein
separ
sdspage
transfer
nitrocellulos
membran
amersham
bioscienc
littl
chalfont
buck
uk
membran
block
nonfat
dri
milk
tb
buffer
mm
trishcl
mm
nacl
ph
incub
h
room
temperatur
primari
antibodi
dilut
tbst
buffer
tb
buffer
contain
tween
nonfat
dri
milk
follow
wash
twice
tbst
buffer
incub
h
room
temperatur
secondari
antibodi
dilut
tbst
buffer
protein
detect
use
sigma
st
loui
mo
usa
super
signal
west
pico
chemiluminesc
substrat
detect
reagent
pierc
accord
manufactur
instruct
na
enzymat
activ
determin
use
endpoint
fluorescencebas
assay
employ
fluorogen
substrat
acid
munana
sigma
st
loui
mo
usa
describ
previous
potier
et
al
brief
l
sampl
mix
equal
volum
assay
buffer
mm
nmorpholino
ethanesulfon
acid
me
ph
contain
mm
cacl
enzymat
reaction
initi
addit
l
munana
follow
min
incub
c
reaction
termin
addit
l
stop
solut
glycin
ph
ethanol
amount
fluoresc
product
releas
measur
victor
v
spectrofluoromet
perkin
elmer
usa
excit
emiss
wavelength
nm
respect
blank
control
reaction
contain
substrat
alon
reaction
conduct
triplic
flatbottom
polystyren
plate
corn
costar
corn
ny
usa
standard
curv
gener
plot
rel
fluoresc
intens
amount
free
one
unit
na
defin
one
micromolar
produc
per
min
c
protein
concentr
determin
use
bradford
method
bovin
serum
albumin
standard
bradford
amount
na
use
determin
micha
constant
k
inhibit
constant
k
unit
obtain
k
valu
assay
perform
presenc
substrat
calcul
fit
data
michaelismenten
equat
use
kaleidagraph
softwar
packag
synergi
softwar
determin
k
valu
na
activ
measur
presenc
nm
oseltamivir
carboxyl
sampl
preincub
inhibitor
c
min
follow
addit
munana
reaction
incub
c
min
termin
stop
solut
fluoresc
intens
measur
describ
fluoresc
intens
reaction
without
inhibitor
taken
maximum
na
activ
v
max
v
max
calcul
k
valu
see
use
determin
k
valu
data
fit
singlesit
competit
inhibit
function
segal
use
kaleidagraph
softwar
packag
synergi
softwar
v
measur
activ
v
max
maximum
activ
inhibitor
concentr
k
inhibit
constant
substrat
concentr
k
micha
constant
calcul
k
k
valu
half
maxim
inhibitori
concentr
ic
oseltamivir
carboxyl
infer
use
equat
ic
k
k
segal
bp
gene
encod
na
head
domain
residu
aviet
viru
clone
express
plasmid
obtain
fig
dna
sequenc
analysi
show
infram
direct
fusion
na
gene
encod
amino
acid
secret
signal
saccharomyc
cervisia
vector
fig
secret
signal
cleavag
site
allow
express
na
effici
releas
yeast
cell
nativ
nterminu
protein
fragment
addit
cmyc
epitop
tag
ctermin
na
allow
detect
purif
express
na
follow
transform
pmeilinear
plasmid
p
pastori
coloni
clone
randomli
select
screen
na
integr
test
clone
yield
expect
pcr
amplicon
size
base
indic
na
gene
integr
p
pastori
genom
fig
smallscal
express
naintegr
clone
neg
control
p
pastori
conduct
use
vv
absolut
methanol
induct
h
incub
cultur
supernat
collect
sdspage
analysi
na
activ
determin
shown
fig
sdspage
reveal
heterogen
protein
kda
produc
integr
clone
hereaft
refer
smear
kda
protein
rel
intens
neg
control
could
repres
differ
form
recombin
na
verifi
presenc
recombin
na
na
activ
fluorescencebas
na
activ
assay
conduct
na
clone
correct
background
fluoresc
due
media
heatinactiv
cultur
supernat
sampl
use
control
blank
na
activ
assay
shown
fig
clone
clone
no
produc
na
activ
unit
lowest
na
activ
unit
observ
clone
no
respect
na
activ
observ
neg
control
variat
na
activ
differ
clone
may
reflect
differ
copi
number
na
gene
integr
yeast
genom
taken
togeth
sdspage
activ
data
indic
head
domain
residu
na
could
express
p
pastori
secret
solubl
protein
measur
na
activ
albeit
low
level
express
compar
typic
recombin
protein
express
p
pastori
optim
na
express
integr
clone
subject
differ
induct
condit
vari
methanol
concentr
vv
incub
time
h
induct
vv
absolut
methanol
period
h
yield
highest
na
activ
unit
cultur
supernat
protein
concentr
mgml
data
shown
condit
use
experi
na
express
yeast
hyperglycosyl
result
multipl
speci
reduc
mobil
rel
unmodifi
na
sdspage
martinet
et
al
expect
size
unmodifi
na
secret
head
domain
kda
thu
observ
smear
kda
protein
integr
clone
fig
could
repres
na
protein
vari
level
glycosyl
sdspage
silver
stain
show
heterogen
proteinband
pattern
similar
coomassi
stain
difficult
distinguish
neg
control
p
pastori
na
gene
integr
fig
lane
lane
howev
nglycosidas
f
treatment
naexpress
p
pastori
cultur
supernat
result
appear
two
protein
kda
concomit
reduct
intens
smear
kda
protein
fig
lane
moreov
glycoprotein
stain
posit
smear
kda
protein
kda
protein
fig
lane
thu
infer
smear
kda
protein
possess
variabl
glycosyl
deglycosyl
gener
two
smaller
protein
demonstr
kda
protein
inde
recombin
na
immunoblot
antihi
fig
antina
antibodi
fig
perform
effici
mous
antisera
recombin
na
commerci
rabbit
polyclon
antina
antibodi
immunoblot
experi
similar
data
shown
therefor
mous
antisera
use
subsequ
experi
kda
protein
recogn
antihi
fig
lane
antina
fig
lane
antibodi
prolong
nglycosidas
f
treatment
reduc
kda
protein
intens
fig
lane
suggest
kda
protein
may
intermedi
glycosyl
statu
kda
form
western
blot
result
thu
show
predomin
glycoform
recombin
na
molecular
weight
approxim
kda
analysi
detergentdisrupt
whole
viral
particl
use
nonreduc
sdspage
shown
presenc
na
protein
kda
johansson
et
al
johansson
kilbourn
viru
na
head
domain
kda
blok
et
al
moreov
kda
monomer
kda
tetramer
form
na
observ
purifi
na
fraction
tanimoto
et
al
taken
togeth
could
suggest
monomer
na
rang
molecular
size
kda
also
observ
viral
na
protein
kda
fig
lane
nonreduc
sdspage
condit
kda
form
data
shown
although
core
peptid
viral
na
kda
size
glycosyl
increas
appar
molecular
weight
kda
recombin
na
lack
transmembran
stalk
region
expect
core
peptid
size
kda
quantit
analysi
nlink
glycosyl
na
reveal
averag
ratio
nacetyldglucosamin
mannos
glucos
residu
per
glycosyl
site
martinet
et
al
lead
postul
increas
molecular
mass
kda
per
glycosyl
site
na
contain
eight
potenti
glycosyl
site
bragstad
et
al
four
site
ser
head
domain
although
presenc
olink
glycosyl
viral
na
demonstr
date
p
pastori
capabl
introduc
nlink
also
olink
glycan
heterolog
protein
bretthauer
castellino
gemmil
trimbl
henc
recombin
na
may
also
contain
addit
long
chain
nlink
glycan
site
olink
glycan
verifi
whether
enzymat
properti
recombin
na
similar
viral
na
specif
na
activ
michaelismenten
constant
k
munana
inhibit
constant
k
oseltamivir
carboxyl
recombin
na
viral
na
determin
reversegenet
virus
use
sourc
viral
na
p
pastori
integr
clone
recombin
na
kinet
studi
perform
use
suspens
allanto
fluid
contain
reversegenet
virus
p
pastori
cultur
supernat
result
show
specif
activ
recombin
na
unitsmg
similar
viral
na
unitsmg
unitsmg
unitsmg
indic
recombin
na
activ
compar
viral
na
k
valu
munana
substrat
recombin
na
viral
na
similar
tabl
k
valu
obtain
studi
similar
report
nativ
virus
rameixwelti
et
al
collin
et
al
rameixwelti
et
al
yen
et
al
could
due
differ
sourc
oseltamivir
carboxyl
variat
assay
condit
although
heterolog
express
na
p
pastori
may
result
differ
glycosyl
viral
na
recombin
viral
na
shown
exhibit
similar
enzymat
properti
consequ
regardless
differ
glycosyl
recombin
viral
na
possess
similar
kinet
properti
base
known
na
structur
russel
et
al
varghes
et
al
white
et
al
glycosyl
site
known
local
surfac
na
head
domain
away
substrat
bind
site
presum
glycosyl
recombin
na
surfac
head
domain
perturb
access
small
substrat
ie
munana
catalyt
site
enzym
nonetheless
vivo
role
glycosyl
effect
molecular
properti
na
unknown
antibodi
direct
ha
appear
greater
effect
viral
infect
na
henc
current
viral
vaccin
focus
ha
hand
ampl
evid
support
use
vaccin
na
help
build
protect
immun
influenza
viru
either
interf
viral
replic
spread
aymard
et
al
jahiel
kilbourn
johansson
et
al
johansson
et
al
kilbourn
et
al
schulman
et
al
webster
et
al
purifi
viral
na
use
supplement
convent
influenza
vaccin
shown
enhanc
immun
respons
virus
johansson
et
al
kilbourn
et
al
schulman
et
al
moreov
recombin
na
deriv
baculovirusexpress
system
induc
naspecif
antibodi
result
reduct
viral
replic
mice
kilbourn
et
al
yeastproduc
na
test
protect
efficaci
influenzachalleng
mice
shown
give
protect
martinet
et
al
thu
immunogen
potenti
na
molecular
mechan
na
protect
antigen
still
interest
issu
worthi
investig
recombin
na
deriv
p
pastori
describ
report
activ
thu
structur
conform
biolog
immunolog
relev
henc
protein
could
use
influenza
vaccin
caveat
extran
cmyc
epitop
tag
peptid
may
interfer
desir
immun
respons
conclus
heterolog
express
avian
influenza
viru
aviet
na
p
pastori
provid
function
activ
na
similar
kinet
properti
viral
na
express
system
provid
simpl
altern
mean
produc
biolog
activ
na
suitabl
highthroughput
screen
novel
inhibitor
biochem
studi
nainhibitor
complex
character
immunogen
properti
avian
influenza
viru
na
studi
use
recombin
na
requir
largescal
express
ferment
system
follow
protein
purif
